Tufts Center for the Study of Drug Development Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Tufts Center for the Study of Drug Development's estimated annual revenue is currently $8.8M per year.(i)
  • Tufts Center for the Study of Drug Development's estimated revenue per employee is $201,000

Employee Data

  • Tufts Center for the Study of Drug Development has 44 Employees.(i)
  • Tufts Center for the Study of Drug Development grew their employee count by 10% last year.

Tufts Center for the Study of Drug Development's People

NameTitleEmail/Phone
1
Director ResearchReveal Email/Phone
2
Senior Data ScientistReveal Email/Phone
3
Senior FellowReveal Email/Phone
4
Senior Research AnalystReveal Email/Phone
5
Tufts CSDDReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3240%$634MN/A
#2
$47.8M2380%N/AN/A
#3
$2.4M12-52%N/AN/A
#4
$25.7M12839%N/AN/A
#5
$12.9M64129%N/AN/A
#6
$23.9M1198%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.3M51-14%N/AN/A
#9
$1.8M367-4%$538MN/A
#10
$50M2493%N/AN/A
Add Company

What Is Tufts Center for the Study of Drug Development?

Our Mission The Tufts Center for the Study of Drug Development is an independent, academic, non-profit research group at Tufts University in Boston, Massachusetts. Our mission is to develop strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical and biopharmaceutical development, review, and utilization. Our path-breaking research informs the research-based industry, regulatory agencies, and the public about the nature and pace of pharmaceutical development Our Objectives * To monitor and report on the development, regulation, and utilization of new drugs and biopharmaceuticals. * To explore the economic, legal, scientific, and public policy issues affecting pharmaceutical and biopharmaceutical innovation worldwide * To serve as an information resource on the development and regulation of new therapeutic agents. * To sponsor public forums and conferences that bring together the perspectives of government, industry, academia, and the public health community. * To raise the level of national and international debate on issues related to new drug and biopharmaceutical product development and regulation.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$8.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M44-2%$22.5M
#2
$10.2M44-6%N/A
#3
$8.8M44-17%N/A
#4
$4.8M44-20%$15M
#5
$3.5M4433%N/A